Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

Merck & Co. isolates novel antifungal agent with potent, broad-spectrum activity

Nov. 18, 1997

Inhibitors of viral neuraminidase from Biota

Nov. 17, 1997

Xoma reports phase II results of Neuprex in trauma patients

Nov. 14, 1997

Cubist acquires rights to daptomycin

Nov. 13, 1997

Suntory's penems are active against MRSA

Nov. 13, 1997

SKB to fund antiinfective research at Australian university

Nov. 12, 1997

Pola's newest antifungal agents disclosed in patent literature

Nov. 12, 1997

ArQule, ViroPharma to collaborate on antiviral drugs

Nov. 12, 1997

Raxar approved in 12 EU countries

Nov. 11, 1997

New oxazolidinone antibiotics described by Zeneca

Nov. 11, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...